Home Medtronic Announces Key Leadership Appointment: Jim Peichel Named New Chief Technology Officer

Medtronic Announces Key Leadership Appointment: Jim Peichel Named New Chief Technology Officer

Nov 21, 2025 09:46 CST Updated 09:46
Medtronic

Medical Device Manufacturer

Image

Source: Medical Device Business Review


Global Medical Device Giant Medtronic Completes Key Technology Leadership Transition.


On November 20, 2025, Jim Peichel officially announced his appointment through the LinkedIn platform.Chief Technology Officer"In a public statement, he emphasized: 'It has been my honor to work with the world's top innovators during my tenure at Medtronic for over 25 years. As the new CTO, I will represent the technology team – they have always been at the core of our mission.'"


6844e8e70243a00755b06c18501d0603.png


This personnel change came just a week after the departure of former Chief Technology and Innovation Officer Ken Washington. According to public information, Washington retired on November 14, 2025. Washington joined Medtronic in 2023 as the company's first Chief Innovation Officer and was a key driver in Medtronic's artificial intelligence field. Prior to that, he served as Vice President and General Manager of Consumer Robotics at Amazon and as Chief Technology Officer at Ford Motor Company.


2a47dd1f6dd626930e656695a685da5a.png

Jim Peichel


Unlike Washington, the new CTO Peichel was promoted internally within Medtronic. According to Peichel's LinkedIn profile, he joined the medical technology giant Medtronic in 1999 as a software engineering intern and gradually advanced in his career. His most recent position was Vice President of the company’s Cardiac Implant Technology Development Center, a role he has held since 2021.


be1d2cd7dd4fa08f41166bdbead5df20.png


Medtronic's cardiovascular business is currently experiencing rapid growth, primarily driven by the success of products such as its Affera pulsed field ablation technology and the leadless Micra pacemaker. On November 18, the company announced second-quarter results that exceeded market expectations, with the cardiovascular business leading the entire company at a 10.8% year-over-year growth.


"Innovation has always been the lifeblood of Medtronic. I believe that we will continue to push boundaries together, explore new technologies, and provide practical and effective solutions for patients around the world. I am grateful for everyone's trust and look forward to the future," said Peichel.


"Thank you to everyone who has supported me along the way. Looking ahead, let us continue to fulfill Medtronic's mission — to alleviate pain, restore health, and extend life."


The content of this article is for reference only and does not constitute investment advice. Readers are expected to effectively distinguish.If any platform reprints this article, it must take responsibility for the content of the article. Medical Device Business Review is not responsible for the impact of secondary dissemination caused by reprinting.


*Advertisement
Recommended Reading
HOT

Click Image to Purchase Directly

图片

In order not to miss any content, everyone remembers toMedical Device Business ReviewSet as Star? Oh,

Looking forward to meeting you at the first moment every time

Image
Share
Image
Favorite
Image
Like
Image
Like